VolitionRx Limited (VNRX) key performance indicators and operating metrics (3 metrics) from SEC EDGAR filings, earnings calls, and investor decks. First-party data.
| Metric | Latest Value | Period |
|---|---|---|
| Non-dilutive funding | 1M | FY2026-Q1 |
| Net at-the-market offering proceeds | 1.2M | FY2026-Q2 |
| Revenue growth | 133.00 percent | FY2025-Q4 |
Back to VNRX overview · VNRX earnings · VNRX holders
Data sourced from U.S. SEC EDGAR filings, earnings call transcripts, and investor decks. Not personalized investment advice.